The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Kuros Biosciences's share price is CHF19.82.
Kuros Biosciences's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2024 was CHF2.02. Hence, Kuros Biosciences's PS Ratio for today is 9.83.
The historical rank and industry rank for Kuros Biosciences's PS Ratio or its related term are showing as below:
XSWX:KURN'
s PS Ratio Range Over the Past 10 Years
Min: 1.81 Med: 13.52 Max: 173.46
Current: 9.83
During the past 13 years, Kuros Biosciences's highest PS Ratio was 173.46. The lowest was 1.81. And the median was 13.52.
XSWX:KURN's PS Ratio is ranked worse than 83.66% of 808
companies
in the Medical Devices & Instruments industry
Industry Median: 3.095
vs XSWX:KURN: 9.83
During the past 12 months, the average Revenue per Share Growth Rate of Kuros Biosciences was 121.20% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 69.00% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 69.30% per year.
During the past 10 years, the average Revenue per Share Growth Rate was -0.80% per year.
During the past 13 years, Kuros Biosciences's highest 3-Year average Revenue per Share Growth Rate was 131.40% per year. The lowest was -78.40% per year. And the median was -1.40% per year.
Back to Basics: PS Ratio
Kuros Biosciences PS Ratio Historical Data
The historical data trend for Kuros Biosciences's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Kuros Biosciences's PS Ratio
For the Medical Devices subindustry, Kuros Biosciences's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kuros Biosciences's PS Ratio Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Kuros Biosciences's PS Ratio distribution charts can be found below:
* The bar in red indicates where Kuros Biosciences's PS Ratio falls into.
Kuros Biosciences PS Ratio Calculation
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Kuros Biosciences's Share Price of today is CHF19.82.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Kuros Biosciences's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2024 was CHF2.02.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Kuros Biosciences (XSWX:KURN) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Kuros Biosciences PS Ratio Related Terms
Thank you for viewing the detailed overview of Kuros Biosciences's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Kuros Biosciences Ltd is a Swiss-based biopharmaceutical company focused on the development of inventive products for tissue repair and bone regeneration. It operates through the following segments: Medical devices, Pharmaceuticals and Legacy portfolio. The Medical devices segment includes products such as MagnetOs and Attrax. The Pharmaceuticals segment includes products such as Fibrin-PTH, a drug-biologic combination that promotes targeted and controlled bone formation through the induction of osteoprogenitor cell differentiation, enhancement, of osteoblast proliferation and increasing the lifespan of bone-forming cells. The Legacy portfolio segment includes all other products that do not belong to the group's core business strategies.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XSWX:KURN has been successfully added to your 